Synergy CHC Corp - SNYR Company profit before taxes, interest and amortization
Synergy CHC Corp's strategy of acquiring niche cosmetic brands has stimulated growth, which is reflected on the GURU.Markets platform in the company's EBITDA, where the 0.00 mark serves as a key metric. Fulfillment automation has ensured high margins, while a broad portfolio of dietary supplements and hygiene products has enabled the holding to compete effectively in retail.
Summary analytical data breakdowns for Synergy CHC (SNYR)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Synergy CHC Corp|SNYR - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Synergy CHC Corp.|SNYR - Company Total Debt|Debts to Book Value Synergy CHC|SNYR - Company Long-Term Debt|Company Short-Term Indebtedness Synergy CHC|Immediate Liquidity synergychc.com
- earnings and market ratios statistics:
SNYR - Company Net Income|Expected Net Income Synergy CHC Corp|SNYR - P/E Multiple|Forward Price to Earnings Multiple Synergy CHC Corp.|SNYR - Price/Earnings to Growth Multiple|Company Value to EBITDA Synergy CHC|SNYR - Operating profit before deduction of amortization|Earnings per share for the trailing year Synergy CHC|SNYR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months synergychc.com|SNYR - Earnings growth in current year
Fundamental company valuation:Synergy CHC Corp
This indicator captures the actual cash flow from core operations before accounting for debt service and asset depreciation, allowing market noise to be stripped away from true profit dynamics. An analysis of EBITDA volatility confirms the operational resilience of Synergy CHC Corp (SNYR), where a steady cash inflow is secured by strict regulation of dietary supplement production and exclusive access to retail shelves.
Competitors of Synergy CHC Corp (SNYR)
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|Operating income before deduction of amortization ANI Pharmaceuticals Inc (ANIP)|MNKD: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Amphastar Corp|Pacira BioSciences (PCRX) - Profit before payment of interest, taxes and amortization|Operating profit before amortization SPRY|TBPH (Theravance Biopharma, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Aquestive Therapeutics Inc AQST|Profit before payment of interest, taxes and amortization scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA TNXP (Tonix Pharmaceuticals)|Operating profit before depreciation charges SXT Pharmaceuticals|EPRX: Operating profit before deduction of amortization|Profit before interest, taxes and amortization BioHarvest Sciences, Inc.|EXOZ (Invizyne Technologies, Inc.) - Operating profit before deduction of amortization|Oramed Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|ENTX (Entera Bio Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization ipatherapeutics.com (HYFT)|Operating profit EBITDA ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA QNTM (Quantum BioPharma Limited)|FGEN - Operating profit before deduction of amortization|TELO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization RANI (Rani Therapeutics)|RLYB: Operating profit EBITDA|Operating profit before deduction of amortization Lexaria Bioscience Corp.|Profit before payment of interest, taxes and amortization Pulmatrix Corp|Profit before interest, taxes and amortization Pheton PTHL|Profit before payment of interest, taxes and amortization Aptorum Group Limited (APM)|LYRA (lyratherapeutics.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Impact BioMedical IBO|TNFA (TNF Pharmaceuticals Inc.) - Profit before deduction of interest, taxes, depreciation and amortization|YCBD - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization PainReform Corp PRFX|altamiratherapeutics.com (CYTO) - Profit before payment of interest, taxes and amortization|Operating profit before amortization LIPO|Operating profit before deduction of amortization OPTN|Profit before interest, taxes and amortization Pieris Pharmaceuticals Inc PIRS|Profit before payment of interest, taxes and amortization Procaps Group SA (PROC)|PTPI (Petros Pharma) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Qilian International QLI|SLRN (acelyrin.com) - Profit before deduction of interest, taxes, depreciation and amortization|TFF Pharmaceuticals, Inc. - Operating profit EBITDA
